Haemato-immunology and histo-architectural changes in Labeo rohita fingerlings: effect of dietary aflatoxin and mould inhibitor.
A feeding trail of 60 days was conducted for delineating the effect of dietary aflatoxin (AFB1) with or without supplementation of a mixture of mould inhibitor (0.25% clove oil + 0.32% sodium propionate) on haematology, respiratory burst activity and histology of Labeo rohita fingerlings. Three hundred and sixty fishes (avg. wt. 1.48-1.54 g) were randomly distributed into eight treatment groups. Eight experimental diets with four different levels of aflatoxin (0, 10, 20 and 40 ppb) with or without mould inhibitor were prepared. Haematological parameters like total serum protein, albumin, globulin and A:G ratio were significantly (P < 0.05) reduced with increasing levels of aflatoxin in the diet. However, supplementation of mould inhibitor showed enhanced values when compared to non-supplemented counter parts suggesting ameliorating effects of mould inhibitor on aflatoxin. Total leucocyte count was higher in aflatoxin-treated groups. Histological observations were complementary to haematological parameters. Respiratory burst activity was significantly (P < 0.05) decreased in higher aflatoxin-treated groups but not affected significantly (P > 0.05) due to inclusion of inhibitor alone and/or interaction of aflatoxin level and inhibitor in the diet. From this study, it was concluded that up to 20 ppb aflatoxin level in the diet the haemato-immunological parameters are protected.
Mohapatra
S
S
Department of Aquaculture, Central Institute of Fisheries Education, Versova, Mumbai, India.
Sahu
N P
NP
Pal
A K
AK
Prusty
A K
AK
Kumar
Vikas
V
Kumar
Shivendra
S
D000348:Aflatoxins / Q000633:toxicity*; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D045783:Clove Oil / Q000494:pharmacology; D003530:Cyprinidae / Q000502:physiology*; D004032:Diet / Q000662:veterinary; D005880:Gills / Q000187:drug effects; D007422:Intestines / Q000187:drug effects; D007668:Kidney / Q000187:drug effects; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects*; D008099:Liver / Q000187:drug effects; D011422:Propionates / Q000494:pharmacology; D016897:Respiratory Burst / Q000187:drug effects
D000348:Aflatoxins; D000935:Antifungal Agents; D045783:Clove Oil; D011422:Propionates; C514135:sodium propionate
J Natl Cancer Inst. 1973 Mar;50(3):767-78
4708154
Prog Exp Tumor Res. 1976;20:317-38
185655
Poult Sci. 1993 Jan;72(1):51-9
8381229
Poult Sci. 1995 Apr;74(4):626-32
7792233
Res Vet Sci. 1994 Jan;56(1):37-40
8146451
Biol Trace Elem Res. 1992 Apr-Jun;33:1-21
1379446
Toxicology. 2001 Oct 15;167(2):101-34
11567776
Comp Immunol Microbiol Infect Dis. 2001 Jul;24(3):143-9
11440188
Fish Shellfish Immunol. 2002 Jan;12(1):1-16
11866127
Dev Comp Immunol. 1996 Nov-Dec;20(6):365-81
9040980
J Toxicol Environ Health. 1996 Jul;48(4):379-96
8691508
Clin Chim Acta. 1971 Jan;31(1):87-96
5544065
Vet Immunol Immunopathol. 1992 Oct;34(1-2):149-58
1441224
Cancer. 1971 Jul;28(1):253-60
4329335